The report "Pharmaceutical Processing Seals Market by Material (Metals, PTFE, Nitrile Rubber, Silicone, EPDM, FKM, FFKM, UHMWPE, PU), Type (O-Ring Seals, Gaskets, Lip Seals, D Seals), Application (Manufacturing Equipment), and Region - Global Forecast to 2026", The pharmaceutical processing seals market is projected to grow from USD 2.1 billion in 2021 to USD 3.3 billion by 2026, at a CAGR of 10.0% during the forecast period. The growth of pharmaceutical processing seals market is attributed to the increased demand for pharmaceutical manufacturing equipment due to the growing healthcare industry and increasing consumption of pharmaceutical drugs. In addition, the expansion of healthcare industry in APAC due to favorable trade policies proposed by the government of countries in this region is expected to drive the pharmaceutical processing seals market.
Silicone is the fastest-growing material for pharmaceutical processing seals. There are very few substitutes available in the market for silicone used in pharmaceutical processing seals as it is considered the most suitable material due to its non-reactiveness when it comes into contact with process fluids. In the pharmaceutical industry, silicone is used for making O-rings, gaskets, and diaphragms which are further used in mixers, pumps, valves, piping flanged joints, transfer equipment, hygienic pipework, reactor vessels, and blenders. The increase in the demand for different types of pharmaceutical manufacturing equipment is expected to drive the market for silicone-based pharmaceutical processing seals.
Trelleborg AB (Sweden), Freudenberg Group (Germany), Flowserve Corporation (US), James Walker (UK), Parker Hannifin Corporation (US), Saint-Gobain S.A. (France), Garlock (US), John Crane (US), IDEX Corporation (US), and Morgan Advanced Materials PLC (UK) are the leading players operating in the pharmaceutical processing seals market.
